MxB decreases the nuclear γH2AX foci induced by L1 retrotransposition. by Yu Huang (15093)

Decreased apoptotic cell death in H9c2 cells treated with OA (caspase activity). by Rudo F. Mapanga (302485)

CNS-<i>Actb</i>KO mice exhibited hyperactivity and decreased performance in the Morris water maze. by Thomas R. Cheever (226943)

<i>Syx5</i> suppression in <i>Drosophila</i> S2 cells decreases copper accumulation. by Melanie Norgate (234832)

Loss of Runx1 in <i>mdx</i> mice decreases muscle mass, muscle strength and lifespan. by Kfir Baruch Umansky (783699)

Inability of macrophages to respond to IL-10 results in decreased persistence of <i>B. abortus in vivo</i>. by Mariana N. Xavier (133803)

H₂O₂ decreases podocyte expression of SD molecules. by Xiqian Lan (219539)

Sustained and repetitive HQ-induced oxidative injury decreases on MCP-1 expression in human RPE cells. by Marianne Pons (355277)

Simulated regional mean wetland seasons. by Nic Gedney (19762301)

TTLL12 knockdown in HEp-2 and DU145 cells decreases cell survival in the presence of nitrotyrosine. by Amit Deshpande (255211)

SCU decreases ischemia area, improves endothelium-dependent vasodilation and influence of PKG inhibitor in MIR rats. by Lin Li (28817)

Male exposure in ewes decreased the content of <i>Tac2</i> mRNA in the rostral ARC. by Julie-Ann P. De Bond (383668)

Blockade of mTORC2 decreased TRPC6-dependent calcium influx in podocytes (confocal microscopy). by Fangrui Ding (659863)

“…Each trace represents the mean value that was derived from 3 cells or fields in a single experiment. …”

Activation of mitoK_ATP channels decreased the latency time of the transjunctional currents in slice. by Jiangping Wang (281901)

“…The control experiment is shown in (<b>A1</b>). (<b>B</b>) Bar graph shows that at 6 min after exposure to DIZ, the latency time was decreased by 50% with an average of 234.54±34.43 µs (n = 13). …”

Decreased type I IFN response in B cells carrying the MS-protective class I alleles. by Christian Lundtoft (4068679)

Image_3_Evidence for Decreased Density of Calretinin-Immunopositive Neurons in the Caudate Nucleus in Patients With Schizophrenia.TIF by Istvan Adorjan (8466846)

“…As expected, small, medium and large CR-ip interneurons were detected in the CN. We found a 38% decrease in the density of all CR-ip interneurons (P < 0.01) that was driven by the loss of the small CR-ip interneurons (P < 0.01) in patients with SCH. …”

Image_2_Evidence for Decreased Density of Calretinin-Immunopositive Neurons in the Caudate Nucleus in Patients With Schizophrenia.TIF by Istvan Adorjan (8466846)

“…As expected, small, medium and large CR-ip interneurons were detected in the CN. We found a 38% decrease in the density of all CR-ip interneurons (P < 0.01) that was driven by the loss of the small CR-ip interneurons (P < 0.01) in patients with SCH. …”

Image_5_Evidence for Decreased Density of Calretinin-Immunopositive Neurons in the Caudate Nucleus in Patients With Schizophrenia.TIF by Istvan Adorjan (8466846)

“…As expected, small, medium and large CR-ip interneurons were detected in the CN. We found a 38% decrease in the density of all CR-ip interneurons (P < 0.01) that was driven by the loss of the small CR-ip interneurons (P < 0.01) in patients with SCH. …”

Image_1_Evidence for Decreased Density of Calretinin-Immunopositive Neurons in the Caudate Nucleus in Patients With Schizophrenia.TIF by Istvan Adorjan (8466846)

“…As expected, small, medium and large CR-ip interneurons were detected in the CN. We found a 38% decrease in the density of all CR-ip interneurons (P < 0.01) that was driven by the loss of the small CR-ip interneurons (P < 0.01) in patients with SCH. …”

Image_4_Evidence for Decreased Density of Calretinin-Immunopositive Neurons in the Caudate Nucleus in Patients With Schizophrenia.TIF by Istvan Adorjan (8466846)

“…As expected, small, medium and large CR-ip interneurons were detected in the CN. We found a 38% decrease in the density of all CR-ip interneurons (P < 0.01) that was driven by the loss of the small CR-ip interneurons (P < 0.01) in patients with SCH. …”